298 related articles for article (PubMed ID: 32493345)
1. Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy.
Shan H; Tian W; Hong Y; Xu B; Wang C; Yu B; Wang X
BMC Complement Med Ther; 2020 Jun; 20(1):166. PubMed ID: 32493345
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
Liu YQ; Lu J; Zhao L; Hou XF; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):605-10. PubMed ID: 26284394
[TBL] [Abstract][Full Text] [Related]
4. Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?
Lai S; Wu P; Diao T; Seery S; Liu J; Hou H; Liu M; Wang J
Jpn J Clin Oncol; 2021 Mar; 51(3):469-477. PubMed ID: 32734304
[TBL] [Abstract][Full Text] [Related]
5. Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
Zhong W; Zhang L; Ma J; Shao S; Lin R; Li X; Xiong G; Fang D; Zhou L
Onco Targets Ther; 2017; 10():5775-5782. PubMed ID: 29255365
[TBL] [Abstract][Full Text] [Related]
6. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center.
Fang D; Zhang L; Li X; Xiong G; Chen X; Han W; He Z; Zhou L
J Cancer Res Clin Oncol; 2014 Mar; 140(3):477-85. PubMed ID: 24469253
[TBL] [Abstract][Full Text] [Related]
9. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
[TBL] [Abstract][Full Text] [Related]
10. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort study.
Milojevic B; Dzamic Z; Grozdic Milojevic I; Bumbasirevic U; Santric V; Kajmakovic B; Janicic A; Durutovic O; Dragicevic D; Bojanic N; Radisavcevic D; Sipetic Grujicic S
Urol Oncol; 2021 Nov; 39(11):786.e9-786.e16. PubMed ID: 34006438
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravesical chemotherapy regimens after radical nephroureterectomy for upper tract urothelial carcinoma and analysis of risk factors for postoperative recurrence.
Jiang SC; Liao YG; Luo J; Hu D; Wang YD; He K
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2387-2395. PubMed ID: 38567601
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
[TBL] [Abstract][Full Text] [Related]
15. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK
Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888
[TBL] [Abstract][Full Text] [Related]
16. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure.
Karanović S; Ardin M; Tang Z; Tomić K; Villar S; Renard C; Venturini E; Lorch AH; Lee DS; Stipančić Ž; Slade N; Vuković Brinar I; Dittrich D; Karlović K; Borovečki F; Dickman KG; Olivier M; Grollman AP; Jelaković B; Zavadil J
Int J Cancer; 2022 Jan; 150(2):374-386. PubMed ID: 34569060
[TBL] [Abstract][Full Text] [Related]
18. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid Nephropathy.
Kanaan N; Hassoun Z; Raggi C; Jadoul M; Mourad M; De Meyer M; Aydin S; Schmeiser HH; Cosyns JP; Goffin E
Transplantation; 2016 Feb; 100(2):416-21. PubMed ID: 26457602
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
